71 studies found for:    "Rubella"
Show Display Options
Rank Status Study
21 Active, not recruiting Coadministration of Measles-rubella and Rotavirus Vaccines
Conditions: Measles Antibody Seroconversion;   Rubella Antibody Seroconversion;   Rotavirus GMT;   Rotavirus IgA Seropositivity
Interventions: Biological: Rotarix vaccine;   Biological: measles-rubella vaccine
22 Unknown  Making Decisions About the Measles-Mumps-Rubella Vaccine
Conditions: Measles;   Mumps;   Rubella;   MMR Vaccination
Intervention: Other: Behavioral: Computer-based tailoring system
23 Completed Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine
Conditions: Measles;   Mumps;   Rubella;   Hepatitis A
Interventions: Biological: Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella;   Biological: Attenuated Measles Mumps Rubella; Inactivated Hep A vaccine
24 Completed Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine
Conditions: Rubella;   Varicella;   Mumps;   Measles
Interventions: Biological: MMRV;   Biological: MMR (Priorix®);   Biological: Varicella (Varilrix®)
25 Recruiting Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life
Conditions: Measles;   Mumps;   Rubella
Interventions: Biological: GSK Biologicals measles, mumps and rubella vaccine live (GSK 209762).;   Biological: Merck & Co., Inc.'s M-M-R®II, combined measles-mumps-rubella virus vaccine live.;   Biological: Varivax® (Merck & Co., Inc.);   Biological: Havrix®;   Biological: Prevnar 13® (Pfizer Inc.)
26 Completed Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.
Conditions: Measles;   Mumps;   Rubella
Intervention: Biological: MMR vaccine (Priorix)
27 Terminated
Has Results
A Study of ProQuad™ in Healthy Children in Korea (V221-023)
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (ProQuad™);   Biological: M-M-R™ II and Varivax™
28 Completed Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly
Conditions: Varicella;   Measles;   Mumps;   Rubella;   Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Hepatitis B;   Haemophilus Infections
Intervention: Biological: ProQuad® and Infanrix® hexa
29 Terminated Immune Responses to Two Dose Varivax +/- MMR-II
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: MMR-II;   Biological: Pro-Quad;   Biological: Varivax
30 Completed ProQuad® rHA Safety
Conditions: Measles;   Mumps;   Rubella;   Varicella
Intervention: Biological: ProQuad® manufactured with rHA
31 Completed Measles, Mumps, and Rubella (MMR) Immunity in College Students
Conditions: Measles;   Mumps;   Rubella
Intervention: Biological: MMR vaccine
32 Terminated Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines
Conditions: Measles;   Mumps;   Rubella;   Varicella
Intervention:
33 Completed
Has Results
Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study
Conditions: Hepatitis A;   Measles;   Mumps;   Rubella;   Chickenpox
Interventions: Biological: VAQTA®;   Biological: ProQuad
34 Completed Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes
Conditions: Measles;   Mumps;   Rubella;   Varicella
Intervention: Biological: MeMuRu-OKA (study vaccine)
35 Completed
Has Results
A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)(COMPLETED)
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: ProQuad (Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live);   Biological: Comparator: M-M-R II;   Biological: Comparator: Varivax;   Biological: Comparator: Placebo
36 Completed
Has Results
Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live;   Biological: Comparator: Varivax;   Biological: Comparator: M-M-R II
37 Active, not recruiting Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children
Conditions: Rubella;   Varicella;   Measles;   Mumps
Interventions: Biological: Priorix Tetra;   Biological: Meningitec
38 Completed
Has Results
ProQuad Dose Selection Study (V221-011)(COMPLETED)
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live;   Biological: Comparator: M-M-R II;   Biological: Comparator: PUVV
39 Completed
Has Results
ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live;   Biological: Comparator: Placebo;   Biological: Comparator: Varivax;   Biological: Comparator: M-M-R II
40 Completed Safety Study of a Refrigerator-Stable Formulation of VARIVAX®
Conditions: Varicella;   Measles;   Mumps;   Rubella
Interventions: Biological: VARIVAX®;   Biological: M-M-RTM II

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years